Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine
暂无分享,去创建一个
C. Di Resta | G. Banfi | M. Plebani | E. Criscuolo | N. Mancini | A. Ambrosi | M. Locatelli | Nicola Clementi | R. Tomaiuolo | Davide Ferrari | Francesca Corea
[1] A. Mangia,et al. Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign , 2021, Clinical chemistry and laboratory medicine.
[2] F. Giuliani,et al. COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection , 2021, International Journal of Technology Assessment in Health Care.
[3] A. Mangia,et al. Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects , 2021, Clinica Chimica Acta.
[4] A. Mangia,et al. Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers , 2021, Vaccines.
[5] Nicola Clementi,et al. Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy , 2021, Viruses.
[6] C. Di Resta,et al. Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects , 2021, Vaccine.
[7] C. Di Resta,et al. The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination—An Analysis of Serological Response and Side Effects , 2021, Vaccines.
[8] J. Mascola,et al. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 , 2021, The New England journal of medicine.
[9] M. Plebani,et al. Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers , 2021, Clinica Chimica Acta.
[10] V. Simon,et al. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine , 2021, The New England journal of medicine.
[11] P. Dormitzer,et al. Neutralizing Activity of BNT162b2-Elicited Serum , 2021, The New England journal of medicine.
[12] M. Sajadi,et al. Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2. , 2021, JAMA.
[13] J. Moon,et al. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals , 2021, The Lancet.
[14] Jonathan C. Brown,et al. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine , 2021, The Lancet.
[15] Bjoern Peters,et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.
[16] J. Dogné,et al. Antibody titres decline 3-month post-vaccination with BNT162b2 , 2021, Emerging microbes & infections.
[17] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.
[18] V. Haselmann,et al. Clinical evaluation of commercial automated SARS-CoV-2 immunoassays , 2020, International Journal of Infectious Diseases.
[19] M. Belingheri,et al. Healthcare Workers , 2020, Journal of occupational and environmental medicine.
[20] E. Walsh,et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults , 2020, Nature.
[21] Nicola Clementi,et al. Poor correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects , 2020, medRxiv.
[22] H. Haslacher,et al. Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity , 2020, medRxiv.
[23] J. Dogné,et al. Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies , 2020, Clinical chemistry.
[24] G. Banfi,et al. Routine blood tests as a potential diagnostic tool for COVID-19 , 2020, Clinical chemistry and laboratory medicine.
[25] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[26] Christine Nardini,et al. Vaccination in the elderly: The challenge of immune changes with aging. , 2018, Seminars in immunology.
[27] G. Banfi,et al. Toxicological investigation in blood samples from suspected impaired driving cases in the Milan area: Possible loss of evidence due to late blood sampling. , 2018, Forensic science international.
[28] Barney S. Graham,et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen , 2017, Proceedings of the National Academy of Sciences.
[29] G. Pennello,et al. Generalized linear mixed models for multi-reader multi-case studies of diagnostic tests , 2017, Statistical methods in medical research.
[30] U. Wiedermann,et al. Primary vaccine failure to routine vaccines: Why and what to do? , 2016, Human vaccines & immunotherapeutics.
[31] V. Yohai. HIGH BREAKDOWN-POINT AND HIGH EFFICIENCY ROBUST ESTIMATES FOR REGRESSION , 1987 .
[32] A. R. Jonckheere,et al. A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVES , 1954 .